Publications:  Dr Alan Johnson

Johnson AP, Wilcox MH(2012). Fidaxomicin: a new option for the treatment of Clostridium difficile infection. J Antimicrob Chemother vol. 67, (12) 2788-2792.

Blackburn RM, Henderson KL, Lillie M, Sheridan E, George RC, Deas AHB, Johnson AP(2011). Empirical treatment of influenza-associated pneumonia in primary care: a descriptive study of the antimicrobial susceptibility of lower respiratory tract bacteria (England, Wales and Northern Ireland, January 2007-March 2010). Thorax vol. 66, (5) 389-395.

Muller-Pebody B, Johnson AP, Heath PT, Gilbert RE, Henderson KL, Sharland M, iCAP Group (Improving Antibiotic Prescribing in Primary Care)(2011). Empirical treatment of neonatal sepsis: are the current guidelines adequate?. Arch Dis Child Fetal Neonatal Ed vol. 96, (1) F4-F8.

Johnson AP(2010). New antibiotics for selective treatment of gastrointestinal infection caused by Clostridium difficile. Expert Opin Ther Pat vol. 20, (10) 1389-1399.

Ladhani S, Pebody RG, Ramsay ME, Lamagni TL, Johnson AP, Sharland M(2010). Continuing impact of infectious diseases on childhood deaths in England and Wales, 2003-2005. Pediatr Infect Dis J vol. 29, (4) 310-313.

Ellington MJ, Hope R, Livermore DM, Kearns AM, Henderson K, Cookson BD, Pearson A, Johnson AP(2010). Decline of EMRSA-16 amongst methicillin-resistant Staphylococcus aureus causing bacteraemias in the UK between 2001 and 2007. J Antimicrob Chemother vol. 65, (3) 446-448.

Henderson KL, Muller-Pebody B, Blackburn RM, Johnson AP(2010). Reduction in erythromycin resistance in invasive pneumococci from young children in England and Wales. J Antimicrob Chemother vol. 65, (2) 369-370.

Henderson KL, Johnson AP, Muller-Pebody B, Charlett A, Gilbert R, Sharland M(2010). The changing aetiology of paediatric bacteraemia in England and Wales, 1998-2007. J Med Microbiol vol. 59, (Pt 2) 213-219.

Henderson KL, Muller-Pebody B, Johnson AP, Goossens H, Sharland M, ARPEC Group(2009). First set-up meeting for Antibiotic Resistance and Prescribing in European Children (ARPEC). Euro Surveill vol. 14, (45)

McNulty CAM, Johnson AP(2008). The European Antibiotic Awareness Day. J Antimicrob Chemother vol. 62, (5) 853-854.

Johnson AP, Waight P, Andrews N, Pebody R, George RC, Miller E(2007). Morbidity and mortality of pneumococcal meningitis and serotypes of causative strains prior to introduction of the 7-valent conjugant pneumococcal vaccine in England. J Infect vol. 55, (5) 394-399.

Johnson AP(2007). Drug evaluation: OPT-80, a narrow-spectrum macrocyclic antibiotic. Curr Opin Investig Drugs vol. 8, (2) 168-173.

Livermore DM, Reynolds R, Stephens P, Duckworth G, Felmingham D, Johnson AP, Murchan S, Murphy O et al.(2006). Trends in penicillin and macrolide resistance among pneumococci in the UK and the Republic of Ireland in relation to antibiotic sales to pharmacies and dispensing doctors. Int J Antimicrob Agents vol. 28, (4) 273-279.

Potz NAC, Hope R, Warner M, Johnson AP, Livermore DM, London & South East ESBL Project Group(2006). Prevalence and mechanisms of cephalosporin resistance in Enterobacteriaceae in London and South-East England. J Antimicrob Chemother vol. 58, (2) 320-326.

Birtles A, Virgincar N, Sheppard CL, Walker RA, Johnson AP, Warner M, Edwards-Jones V, George RC(2004). Antimicrobial resistance of invasive Streptococcus pneumoniae isolates in a British district general hospital: the international connection. J Med Microbiol vol. 53, (Pt 12) 1241-1246.

Johnson AP, Mushtaq S, Warner M, Livermore DM(2004). Activity of daptomycin against multi-resistant Gram-positive bacteria including enterococci and Staphylococcus aureus resistant to linezolid. Int J Antimicrob Agents vol. 24, (4) 315-319.

Woodford N, Ward ME, Kaufmann ME, Turton J, Fagan EJ, James D, Johnson AP, Pike R et al.(2004). Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum beta-lactamases in the UK. J Antimicrob Chemother vol. 54, (4) 735-743.

Mushtaq S, Warner M, Johnson AP, Livermore DM(2004). Activity of dalbavancin against staphylococci and streptococci, assessed by BSAC and NCCLS agar dilution methods. J Antimicrob Chemother vol. 54, (3) 617-620.

Johnson AP, Mushtaq S, Warner M, Livermore DM(2004). Calcium-supplemented daptomycin Etest strips for susceptibility testing on Iso-Sensitest agar. J Antimicrob Chemother vol. 53, (5) 860-862.

Weisner AM, Johnson AP, Lamagni TL, Arnold E, Warner M, Heath PT, Efstratiou A(2004). Characterization of group B streptococci recovered from infants with invasive disease in England and Wales. Clin Infect Dis vol. 38, (9) 1203-1208.

Potz NAC, Mushtaq S, Johnson AP, Henwood CJ, Walker RA, Varey E, Warner M, James D et al.(2004). Reliability of routine disc susceptibility testing by the British Society for Antimicrobial Chemotherapy (BSAC) method. J Antimicrob Chemother vol. 53, (5) 729-738.

Stockdale MW, Tysall L, Johnson AP, Livermore DM, Woodford N(2004). Low in vitro selection frequencies of enterococcal and staphylococcal mutants resistant to the oxazolidinone AZD2563. Int J Antimicrob Agents vol. 23, (1) 88-91.

Johnson AP, Sheppard CL, Harnett SJ, Birtles A, Harrison TG, Brenwald NP, Gill MJ, Walker RA et al.(2003). Emergence of a fluoroquinolone-resistant strain of Streptococcus pneumoniae in England. J Antimicrob Chemother vol. 52, (6) 953-960.

Johnson AP(2003). Antibiotic resistance in the intensive care unit setting. Expert Rev Anti Infect Ther vol. 1, (2) 253-260.

Fenton KA, Ison C, Johnson AP, Rudd E, Soltani M, Martin I, Nichols T, Livermore DM et al.(2003). Ciprofloxacin resistance in Neisseria gonorrhoeae in England and Wales in 2002. Lancet vol. 361, (9372) 1867-1869.